Article
Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature.
Oncotarget - 20 Sept 2016
Jung Jaeyun, Lee Cue Hyunkyu, Seol Hyang Sook, Choi Yeon Sook, Kim Eunji, Lee Eun Ji, Rhee Je-Keun, Singh Shree Ram, Jun Eun Sung, Han Buhm, Hong Seung Mo, Kim Song Cheol, Chang Suhwan
Abstract excerpt
Pancreatic ductal adenocarcinoma (PDAC) is the most challenging type of cancer to treat, with a 5-year survival rate of <10%. Furthermore, because of the large portion of the inoperable cases, it is difficult to obtain specimens to study the biology of the tumors. Therefore, a patient-derived xenograft (PDX) model is an attractive option for preserving and expanding these tumors for translational research. Here...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
